Neurological Diseases/Parkinson’s

Hydrogen therapy: from mechanism to cerebral diseases

The medicinal value of hydrogen (H2) was ignored prior to research illustrating that inhalation of 2% H2 can significantly decrease the damage of cerebral ischemia/reperfusion caused by oxidative stress via selective elimination of hydroxyl freebase (OH) and peroxynitrite anion (ONOOˉ).

Medical gases for stroke therapy: summary of progress 2015–2016

Stroke is a cerebrovascular disease with high mortality and morbidity. Despite extensive research, there are only a very limited number of therapeutic approaches suitable for treatment of stroke patients as yet.

Therapeutic Effects of Hydrogen in Animal Models of Parkinson’s Disease

Since the first description of Parkinson’s disease (PD) nearly two centuries ago, a number of studies have revealed the clinical symptoms, pathology, and therapeutic approaches to overcome this intractable neurodegenerative disease.

Inhalation of hydrogen gas elevates urinary 8-hydroxy-2′-deoxyguanine in Parkinson’s disease

Hyposmia is one of the earliest and the most common symptoms in Parkinson’s disease (PD). The benefits of hydrogen water on motor deficits have been reported in animal PD models and PD patients, but the effects of hydrogen gas on PD patients have not been studied.

Case Report on a Novel Application of Molecular Hydrogen Inhalation Therapy for Parkinson’s Disease and Persistent Post-Concussive Syndrome

Background A 72-year-old female attendee at the AMMG conference in Doral, FL, with Parkinson’s disease (PD) and severe tremors, which were affecting her quality of life (i.e., difficulty eating, putting on makeup, using her phone, difficulty walking and talking). She stopped at the Hue Light USA booth. She stated that she had experienced a concussion […]

Shopping cart (0)

No products in the cart.

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.